How can we create more standardized health information platforms that can easily exchange patient information?
Joseph Alvarnas, MD, asked the panelists' thoughts on a proposed timeline for when patients and the healthcare system could anticipate a technological fix to the existing problem of interoperability.
Rebekkah Schear, MIA, said that several patient-friendly apps have been developed that ensure patients have access to their health information and a line of communication with their care provider. Schear also highlighted the importance of wearable devices for a more real-time sharing of patient information with their care provider(s).
"I think the general point is there has to be a balance between having immediate access to most things in our lives from a communications perspective and knowing that the health sector is going to be a little bit slower to catch up," Schear said. "But at the same time, we need to overcome this thick barrier between providers and patients where provides aren't necessarily able and available to connect with patients with immediacy. There needs to be some sort of balance there," she added.
Both Schear and Michael Kolodziej, MD, agreed that the evolution of HIPAA is inevitable and it has to keep pace with the technological advances within healthcare.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
March 22nd 2024Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma.
Read More